Expand VERU Menu
VERU MENU

VERU Latest Press Releases

-- December 17, 2025 --

Veru Reports Fiscal Year 2025 Financial Results and Clinical Program Progress Globe Newswire 6:30 AM

-- December 10, 2025 --

Veru to Report Fiscal Year 2025 Financial Results on December 17th Globe Newswire 8:30 AM

-- December 4, 2025 --

Veru to Present at The Society on Sarcopenia, Cachexia, and Wasting Disorders 18th International Conference and Regulatory and Clinical Trials Update Regulatory Workshop Globe Newswire 8:30 AM

-- October 31, 2025 --

Veru to Present Two Abstracts at ObesityWeek 2025 Globe Newswire 8:30 AM

-- October 30, 2025 --

Veru Announces Pricing of $25 Million Public Offering Globe Newswire 8:00 AM

-- October 29, 2025 --

Veru Announces Proposed Public Offering Globe Newswire 4:01 PM

-- September 23, 2025 --

Veru Announces Successful FDA Meeting Providing Regulatory Clarity for Enobosarm for Muscle Preservation in Combination with GLP-1 RA for Greater Weight Loss in the Treatment of Obesity Globe Newswire 8:30 AM

-- August 12, 2025 --

Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress Globe Newswire 6:30 AM

-- August 11, 2025 --

Laxxon Medical Announces Successful Product Development Milestone with Novel Oral Modified-Release Formulation of Veru's Enobosarm, Utilizing Laxxon's SPID-Technology Business Wire 4:01 PM
Veru Announces Selection of Novel Modified Release Oral Enobosarm Formulation for Chronic Weight Loss Management Following Pharmacokinetic Clinical Study Globe Newswire 8:30 AM

-- August 6, 2025 --

Veru Announces Reverse Stock Split Globe Newswire 8:30 AM

-- August 5, 2025 --

Veru to Report Fiscal 2025 Third Quarter Financial Results on August 12th Globe Newswire 8:30 AM

-- July 22, 2025 --

Veru to Participate in the 2025 BTIG Virtual Biotech Conference Globe Newswire 8:30 AM
Market Data Delayed 15 Minutes